Latest News
Johnson and Johnson Medical Acquires Germany´s Emerging Implant Technologies
Thursday 13 September 2018

13 September 2018 - US-based healthcare company Johnson and Johnson's (NYSE: JNJ) Johnson and Johnson Medical Devices Companies business, through a German subsidiary, has acquired German 3D-printed titanium interbody implants manufacturer Emerging Implant Technologies GmbH, the company said.

Emerging Implant Technologies is a privately held manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery, based in Wurmlingen.

The products in this portfolio leverage EIT's proprietary advanced cellular titanium, which consists of an open and interconnected porous structure designed to allow bone to grow into the implant.

Active across the range of orthopaedic and spine specialties, Johnson and Johnson Medical Devices Companies will leverage its global commercial infrastructure to bring EIT's technologies to patients around the world.

This acquisition allows DePuy Synthes, the orthopaedics business of Johnson and Johnson, to enhance its comprehensive interbody implant portfolio that includes expandable interbody devices, titanium integrated PEEK technology and now 3D-printed cellular titanium, for both minimally invasive and open spinal surgery.

The EIT technology complements DePuy Synthes' investment in the interbody implant segment in spine, including the recent introductions of the Concorde Lift Expandable Interbody Device, and in the US, the PROTI 360° Family of Titanium-Integrated Interbody Implants, designed to treat patients with degenerative disc disease.

This acquisition underscores the companies' commitment to building an innovative portfolio of spine solutions to improve the standard of care for patients. 

Moving forward, DePuy Synthes will continue to focus on the spinal disease states with the most potential for surgeons and their patients degenerative disc disease, deformity and complex cervical and introduce technologies in the fastest-growing segments within these disease states; specifically, interbody implants, enabling technologies, minimally invasive spine, and biomaterials.

Financial terms of the transaction will not be disclosed.

DePuy Synthes, part of the Johnson and Johnson Medical Devices Companies, provides one of the most comprehensive orthopaedics portfolios in the world. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide.
Details
Date Published: 13/09/2018
Target: Emerging Implant Technologies
Country: Germany
Sector: Healthcare
Type: Corporate acquisition
Financing:
Status: Closed
Vendor:
Buyer: Johnson and Johnson Medical Devices Companies
Comment:
Terms of the deal were not disclosed

Options